Hex-EN (Hexedrone)
Price range: $150 through $1,200
Description
Hex-EN (also known as N-Ethylhexedrone, Hexen, or NEH) is a potent stimulant belonging to the synthetic cathinone class. It is chemically related to pentedrone and hexedrone and is often classified as a research chemical or “designer drug” due to its relatively recent appearance in the recreational market around 2015.
National Institutes of Health (NIH) | (.gov) +3
Key Characteristics
- Pharmacology: It acts as a norepinephrine–dopamine reuptake inhibitor (NDRI). This means it increases the concentration of these neurotransmitters in the brain, leading to stimulating effects.
- Effects: Users report intense euphoria, increased energy, thought acceleration, and social disinhibition.
- Risks: Due to its fast onset and short duration, it has a high potential for abuse and can be moderately to highly addictive. Reported side effects include irritation to the respiratory system, skin, and eyes, as well as severe cardiovascular strain.
- Legal Status: In March 2020, it was added to Schedule II of the UN Convention on Psychotropic Substances due to its public health risks. In the United States, it is a DEA Schedule I controlled substance.
National Institutes of Health (NIH) | (.gov) +9
Distinction from Similar Names
Hex-EN should not be confused with:
- Hexedrone: The parent compound, which lacks the ethyl group found in N-Ethylhexedrone.
- Hexene: A common industrial hydrocarbon used in chemical manufacturing, not a psychoactive drug.
- Hexane: A solvent and neurotoxin used in industrial processes. What specific information are you looking for regarding Hex-EN?
- Detailed pharmacological profiles
- Current legal status in a specific country
- Information on health risks and toxicity
Additional information
| Quantity | 2g, 5g, 10g |
|---|




Reviews
There are no reviews yet.